Gland Pharma Limited (NSE:GLAND)
India flag India · Delayed Price · Currency is INR
1,642.00
+8.40 (0.51%)
Jun 6, 2025, 3:30 PM IST

Revenue by Product

Fiscal year is April - March.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2017 - 2018
Period Ending
Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 2017 - 2018
Generic Injectibles
56.65B
Log In
Log In
Log In
Log In
Upgrade
Generic Injectibles Growth
56.29%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is April - March.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2017 - 2018
Period Ending
Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 2017 - 2018
United States
26.88B
Log In
Log In
Log In
Log In
Upgrade
United States Growth
28.54%
Log In
Log In
Log In
Log In
Upgrade
Rest of World
11.82B
Log In
Log In
Log In
Log In
Upgrade
Rest of World Growth
71.43%
Log In
Log In
Log In
Log In
Upgrade
Europe
10.53B
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
462.62%
Log In
Log In
Log In
Log In
Upgrade
India
5.88B
Log In
Log In
Log In
Log In
Upgrade
India Growth
5.97%
Log In
Log In
Log In
Log In
Upgrade
Canada
890.27M
Log In
Log In
Log In
Log In
Upgrade
Canada Growth
12.00%
Log In
Log In
Log In
Log In
Upgrade
Australia
626.45M
Log In
Log In
Log In
Log In
Upgrade
Australia Growth
187.05%
Log In
Log In
Log In
Log In
Upgrade
New Zealand
28.17M
Log In
Log In
Log In
Log In
Upgrade
New Zealand Growth
159.39%
Log In
Log In
Log In
Log In
Upgrade